指南与共识胸部肿瘤

区分独立原发肺腺癌与肺内转移:聚焦病理与分子考量——国际肺癌研究协会病理委员会推荐

Differentiating Separate Primary Lung Adenocarcinomas From Intrapulmonary Metastases With Emphasis on Pathological and Molecular Considerations: Recommendations From the International Association for the Study of Lung Cancer Pathology Committee.
指南 / 共识 · J Thorac Oncol · 2024-11-22

国际肺癌研究协会病理委员会系统综述了组织病理学与分子检测(微卫星分析、阵列比较基因组杂交、TP53及驱动基因突变检测、下一代测序多基因panel)在区分独立原发肺癌(SPLC)与肺内转移(IPM)中的作用,并提出联合四步组织学与分子分类算法,鼓励多学科协作。

要点

  • 综合组织学评估可能足以区分SPLC与IPM。
  • 更大规模的下一代测序分子分型通常提供更优的判别力,可实现更准确分类。
  • 基于文献综述与专家意见提出联合四步组织学与分子分类算法,鼓励多学科协作。

核心结论

  • 组织病理学评估通常足以区分SPLC与IPM,但条件允许时应进行分子分型,尤其是形态相似的肿瘤。

研究设计与样本

  • 国际肺癌研究协会病理委员会系统综述了组织病理学评估与分子分型(DNA微卫星分析、阵列比较基因组杂交、TP53及致癌驱动突变检测、下一代测序多基因panel)在区分SPLC与IPM中的方法。

主要发现

  • 综合组织学评估可能足以区分SPLC与IPM,但更大规模的下一代测序分子分型通常提供更优判别力,实现更准确分类。
  • 基于文献综述与专家意见提出联合四步组织学与分子分类算法,用于处理腺癌组织学的多发性肺肿瘤结节,鼓励多学科协作。
  • 结合机器学习与数字病理的新技术未来可能成为区分SPLC与IPM的有价值诊断工具。

关键数值与推荐

  • 推荐采用联合四步组织学与分子分类算法处理腺癌组织学的多发性肺肿瘤结节,并鼓励多学科协作。

临床怎么用

  • 组织病理学评估通常足以区分SPLC与IPM,条件允许时应进行分子分型,尤其形态相似肿瘤。
  • 可依据联合四步组织学与分子分类算法对多发性肺腺癌结节进行分类,鼓励多学科协作。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: With the implementation of low-dose computed tomography screening, multiple pulmonary tumor nodules are diagnosed with increasing frequency and the selection of surgical treatments versus systemic therapies has become challenging on a daily basis in clinical practice. In the presence of multiple carcinomas, especially adenocarcinomas, pathologically determined to be of pulmonary origin, the distinction between separate primary lung carcinomas (SPLCs) and intrapulmonary metastases (IPMs) is important for staging, management, and prognostication. METHODS: We systemically reviewed various means that aid in the differentiation between SPLCs and IPMs explored by histopathologic evaluation and molecular profiling, the latter includes DNA microsatellite analysis, array comparative genomic hybridization, TP53 and oncogenic driver mutation testing and, more recently, with promising effectiveness, next-generation sequencing comprising small- or large-scale multi-gene panels. RESULTS: Comprehensive histologic evaluation may suffice to differentiate between SPLCs and IPMs. Nevertheless, molecular profiling using larger-scale next-generation sequencing typically provides superior discriminatory power, allowing for more accurate classification. On the basis of the literature review and expert opinions, we proposed a combined four-step histologic and molecular classification algorithm for addressing multiple pulmonary tumor nodules of adenocarcinoma histology that encourages a multidisciplinary approach. It is also noteworthy that new technologies combining machine learning and digital pathology may develop into valuable diagnostic tools for distinguishing SPLCs from IPMs in the future. CONCLUSIONS: Although histopathologic evaluation is often adequate to differentiate SPLCs from IPMs, molecular profiling should be performed when possible, especially in cases with tumors exhibiting similar morphology. This manuscript summarized the previous efforts in resolving the current challenges and highlighted the recent progress in the differentiation methods and algorithms used in categorizing multiple lung adenocarcinomas into SPLCs or IPMs, which are becoming more and more critical in precision lung cancer management.

来源:J Thorac Oncol,查看原文。版权归原作者所有。

引用

  1. Chou TY, Dacic S, Wistuba I, et al. Differentiating Separate Primary Lung Adenocarcinomas From Intrapulmonary Metastases With Emphasis on Pathological and Molecular Considerations: Recommendations From the International Association for the Study of Lung Cancer Pathology Committee. J Thorac Oncol. 2024. PMID: 39579981. doi:10.1016/j.jtho.2024.11.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。